Abraham Ceesay - Net Worth and Insider Trading
Abraham Ceesay Net Worth
The estimated net worth of Abraham Ceesay is at least $0 dollars as of 2024-11-07. Abraham Ceesay is the President of Cerevel Therapeutics Holdings Inc and owns about 0 shares of Cerevel Therapeutics Holdings Inc (CERE) stock worth over $0. Details can be seen in Abraham Ceesay's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Abraham Ceesay has not made any transactions after 2022-09-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Abraham Ceesay
Abraham Ceesay Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Abraham Ceesay owns 3 companies in total, including scPharmaceuticals Inc (SCPH) , Cerevel Therapeutics Holdings Inc (CERE) , and Pacira BioSciences Inc (PCRX) .
Click here to see the complete history of Abraham Ceesay’s form 4 insider trades.
Insider Ownership Summary of Abraham Ceesay
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SCPH | scPharmaceuticals Inc | 2017-11-16 | Chief Operating Officer |
| CERE | Cerevel Therapeutics Holdings Inc | 2022-09-08 | President |
| PCRX | Pacira BioSciences Inc | 2023-10-06 | director |
Abraham Ceesay Latest Holdings Summary
Abraham Ceesay currently owns a total of 1 stock. Abraham Ceesay owns 0 shares of Cerevel Therapeutics Holdings Inc (CERE) as of September 8, 2022, with a value of $0.
Latest Holdings of Abraham Ceesay
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CERE | Cerevel Therapeutics Holdings Inc | 2022-09-08 | 0 | 44.96 | 0 |
Holding Weightings of Abraham Ceesay
Abraham Ceesay Form 4 Trading Tracker
According to the SEC Form 4 filings, Abraham Ceesay has made a total of 4 transactions in Cerevel Therapeutics Holdings Inc (CERE) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Cerevel Therapeutics Holdings Inc is the sale of 19,210 shares on September 8, 2022, which brought Abraham Ceesay around $624,325.
Insider Trading History of Abraham Ceesay
- 1
Abraham Ceesay Trading Performance
Abraham Ceesay Ownership Network
Ownership Network List of Abraham Ceesay
Ownership Network Relation of Abraham Ceesay
Abraham Ceesay Owned Company Details
What does scPharmaceuticals Inc do?
Who are the key executives at scPharmaceuticals Inc?
Abraham Ceesay is the Chief Operating Officer of scPharmaceuticals Inc. Other key executives at scPharmaceuticals Inc include 10 percent owner Orbimed Advisors Llc , 10 percent owner 5am Partners Iv, Llc , and director & President and CEO John H Tucker .
scPharmaceuticals Inc (SCPH) Insider Trades Summary
Over the past 18 months, Abraham Ceesay made no insider transaction in scPharmaceuticals Inc (SCPH). Other recent insider transactions involving scPharmaceuticals Inc (SCPH) include a net purchase of 500,000 shares made by Orbimed Advisors Llc ,
In summary, during the past 3 months, insiders sold 0 shares of scPharmaceuticals Inc (SCPH) in total and bought 500,000 shares, with a net purchase of 500,000 shares. During the past 18 months, 0 shares of scPharmaceuticals Inc (SCPH) were sold and 500,000 shares were bought by its insiders, resulting in a net purchase of 500,000 shares.
scPharmaceuticals Inc (SCPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
scPharmaceuticals Inc Insider Transactions
Abraham Ceesay Mailing Address
Above is the net worth, insider trading, and ownership report for Abraham Ceesay. You might contact Abraham Ceesay via mailing address: C/o Scpharmaceuticals, Inc., 2400 District Avenue Suite 310, Burlington Ma 01830.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
